Synopsis of recent research by authors named "Kelly A Munoz"
- Kelly A Munoz's recent research primarily focuses on the safety, pharmacokinetics, and bioavailability of the novel antibacterial tedizolid, particularly in relation to its potential neurological and ophthalmological side effects.
- The studies conducted by Munoz include assessments of tedizolid's pharmacokinetics in healthy volunteers, examining both oral and intravenous administration, as well as the drug's efficacy in minimizing mitochondrial toxicity.
- Findings from Munoz's work indicate that tedizolid may have a favorable safety profile concerning optic and peripheral neuropathies, while demonstrating effective pharmacokinetics and tolerability for treating gram-positive infections.
